Correlation Between Novartis and Roche Holding

Can any of the company-specific risk be diversified away by investing in both Novartis and Roche Holding at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Novartis and Roche Holding into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Novartis AG and Roche Holding AG, you can compare the effects of market volatilities on Novartis and Roche Holding and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Novartis with a short position of Roche Holding. Check out your portfolio center. Please also check ongoing floating volatility patterns of Novartis and Roche Holding.

Diversification Opportunities for Novartis and Roche Holding

0.96

Correlation Coefficient

Novartis  Roche Holding

Almost no diversification

The 3 months correlation between Novartis and Roche is 0.96. Overlapping area represents the amount of risk that can be diversified away by holding Novartis AG and Roche Holding AG in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Roche Holding AG and Novartis is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Novartis AG are associated (or correlated) with Roche Holding. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Roche Holding AG has no effect on the direction of Novartis i.e., Novartis and Roche Holding go up and down completely randomly.

Pair Corralation between Novartis and Roche Holding

Assuming the 90 days trading horizon Novartis is expected to generate 1.29 times less return on investment than Roche Holding. But when comparing it to its historical volatility, Novartis AG is 1.01 times less risky than Roche Holding. It trades about 0.2 of its potential returns per unit of risk. Roche Holding AG is currently generating about 0.26 of returns per unit of risk over similar time horizon. If you would invest  24,839  in Roche Holding AG on December 31, 2024 and sell it today you would earn a total of  4,831  from holding Roche Holding AG or generate 19.45% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Very Strong
Accuracy	100.0%
Values	Daily Returns

Novartis AG  vs.  Roche Holding AG

Novartis AG

Risk-Adjusted Performance

Solid

Compared to the overall equity markets, risk-adjusted returns on investments in Novartis AG are ranked lower than 15 (%) of all global equities and portfolios over the last 90 days. In spite of fairly abnormal basic indicators, Novartis showed solid returns over the last few months and may actually be approaching a breakup point.

Roche Holding AG

Risk-Adjusted Performance

Solid

Compared to the overall equity markets, risk-adjusted returns on investments in Roche Holding AG are ranked lower than 20 (%) of all global equities and portfolios over the last 90 days. In spite of fairly weak technical and fundamental indicators, Roche Holding showed solid returns over the last few months and may actually be approaching a breakup point.

Pair Trading with Novartis and Roche Holding

The main advantage of trading using opposite Novartis and Roche Holding positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Novartis position performs unexpectedly, Roche Holding can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Roche Holding will offset losses from the drop in Roche Holding's long position.

The idea behind Novartis AG and Roche Holding AG pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Risk-Return Analysis module to view associations between returns expected from investment and the risk you assume.